InvestorsHub Logo
Followers 13
Posts 697
Boards Moderated 0
Alias Born 01/12/2013

Re: dovo post# 114341

Thursday, 05/21/2015 8:41:14 PM

Thursday, May 21, 2015 8:41:14 PM

Post# of 130503
Great question!. Perhaps its just a filing and intention to R/S the shares (sort of like increasing your Authorized shares but never using all of them). We dont know what transactions might occur before the R/S split is triggered:

1) Could they have sold the Diagnostic division?

2) Could ESS (Cutagen) be sold)? Interesting how that deal never closed yet...could have been courting buyers and wanted the best deal. I still dont think this asset is a strategic fit into the company anyway.

3) Could we have a Partnership somewhere aligned to one of our most signficant assets (MANF - RP, Eltoprazine, ESS or maybe even on LymPro)?

Its possible that we wake up tomorrow and the R/S is already converted at a $.05 or $.055 strike price...and we are Up listed on Nasdaq next Tuesday or Wednesday. Its very interesting how the Conference call (next Wed.) was delayed a week after the actual Q1 Earnings announcement.

Stay tuned!!!